Putnam Investments LLC Ascendis Pharma A/S Transaction History
Putnam Investments LLC
- $73 Billion
- Q4 2023
A detailed history of Putnam Investments LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Putnam Investments LLC holds 725,651 shares of ASND stock, worth $123 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
725,651
Previous 772,362
6.05%
Holding current value
$123 Million
Previous $72.3 Million
26.37%
% of portfolio
0.13%
Previous 0.11%
Shares
22 transactions
Others Institutions Holding ASND
# of Institutions
236Shares Held
60.2MCall Options Held
80.3KPut Options Held
216K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.71 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$933 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$862 Million10.24% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.45MShares$751 Million0.98% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$740 Million0.32% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $9.42B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...